Skip Navigation
Skip to contents

JPMPH : Journal of Preventive Medicine and Public Health

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Ju-Young Kim 1 Article
Levothyroxine Dose and Fracture Risk According to the Osteoporosis Status in Elderly Women
Young-Jin Ko, Ji Young Kim, Joongyub Lee, Hong-Ji Song, Ju-Young Kim, Nam-Kyong Choi, Byung-Joo Park
J Prev Med Public Health. 2014;47(1):36-46.   Published online January 29, 2014
DOI: https://doi.org/10.3961/jpmph.2014.47.1.36
  • 12,280 View
  • 172 Download
  • 24 Crossref
AbstractAbstract PDF
Objectives

To evaluate the association between fracture risk and levothyroxine use in elderly women with hypothyroidism, according to previous osteoporosis history.

Methods

We conducted a cohort study from the Korean Health Insurance Review and Assessment Service claims database from January 2005 to June 2006. The study population comprised women aged ≥65 years who had been diagnosed with hypothyroidism and prescribed levothyroxine monotherapy. We excluded patients who met any of the following criteria: previous fracture history, hyperthyroidism, thyroid cancer, or pituitary disorder; low levothyroxine adherence; or a follow-up period <90 days. We categorized the daily levothyroxine doses into 4 groups: ≤50 µg/d, 51 to 100 µg/d, 101 to 150 µg/d, and >150 µg/d. The hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated with the Cox proportional hazard model, and subgroup analyses were performed according to the osteoporosis history and osteoporosis-specific drug prescription status.

Results

Among 11 155 cohort participants, 35.6% had previous histories of osteoporosis. The adjusted HR of fracture for the >150 µg/d group, compared with the 51 to 100 µg/d group, was 1.56 (95% CI, 1.03 to 2.37) in osteoporosis subgroup. In the highly probable osteoporosis subgroup, restricted to patients who were concurrently prescribed osteoporosis-specific drugs, the adjusted HR of fracture for the >150 µg/d group, compared with the 51 to 100 µg/d group, was 1.93 (95% CI, 1.14 to 3.26).

Conclusions

While further studies are needed, physicians should be concerned about potential levothyroxine overtreatment in elderly osteoporosis patients.

Summary

Citations

Citations to this article as recorded by  
  • Diagnosis and therapeutic approach to bone health in patients with hypopituitarism
    Justyna Kuliczkowska-Płaksej, Aleksandra Zdrojowy-Wełna, Aleksandra Jawiarczyk-Przybyłowska, Łukasz Gojny, Marek Bolanowski
    Reviews in Endocrine and Metabolic Disorders.2024; 25(3): 513.     CrossRef
  • Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes
    Amit Akirov, Yaron Rudman, Maria Fleseriu
    Pituitary.2024;[Epub]     CrossRef
  • Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association
    A Ram Hong, Ho-Cheol Kang
    Endocrinology and Metabolism.2023; 38(2): 175.     CrossRef
  • Refractory Hypothyroidism: Unraveling the Complexities of Diagnosis and Management
    Juan Eduardo Quiroz-Aldave, Marcio José Concepción-Zavaleta, María del Carmen Durand-Vásquez, Luis Alberto Concepción-Urteaga, Elman Rolando Gamarra-Osorio, Jacsel Suárez-Rojas, Luciana del Pilar Rafael-Robles, José Paz-Ibarra, Alejandro Román-González
    Endocrine Practice.2023; 29(12): 1007.     CrossRef
  • Assessing the cardiovascular effects of levothyroxine use in an ageing United Kingdom population (ACEL-UK) protocol: a cohort and target trial emulation study
    Mia Holley, Salman Razvi, Rosie Dew, Ian Maxwell, Scott Wilkes
    Thyroid Research.2023;[Epub]     CrossRef
  • Understanding Worry About Risks Associated With Thyroid Hormone Therapy: A National Survey of Endocrinologists, Family Physicians, and Geriatricians
    Kimi Shah, David Reyes-Gastelum, Brittany L. Gay, Maria Papaleontiou
    Endocrine Practice.2022; 28(1): 25.     CrossRef
  • Evaluation and Management of Bone Health in Patients with Thyroid Diseases: a Position Statement from the Korean Thyroid Association
    A Ram Hong, Hwa Young Ahn, Bu Kyung Kim, Seong Hee Ahn, So Young Park, Min-Hee Kim, Jeongmin Lee, Sun Wook Cho, Ho-Cheol Kang
    International Journal of Thyroidology.2022; 15(1): 1.     CrossRef
  • Levothyroxine Therapy in Elderly Patients With Hypothyroidism
    Grigoris Effraimidis, Torquil Watt, Ulla Feldt-Rasmussen
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Systemic medicines taken by adult special care dental patients and implications for the management of their care
    Nicholas Ransford, Ben Marnell, Christine Randall, Clare Yates, Gillian Howie
    British Dental Journal.2021; 231(1): 33.     CrossRef
  • The Influence of Thyroid Pathology on Osteoporosis and Fracture Risk: A Review
    Dragos Apostu, Ondine Lucaciu, Daniel Oltean-Dan, Alexandru-Dorin Mureșan, Cristina Moisescu-Pop, Andrei Maxim, Horea Benea
    Diagnostics.2020; 10(3): 149.     CrossRef
  • Comparison of the efficacy between once-monthly oral ibandronate and risedronate among Korean women with osteoporosis: a nationwide population-based study
    Dong Ryul Lee, Jungun Lee
    Osteoporosis International.2019; 30(3): 659.     CrossRef
  • The effect of thyroid functions on osteopenia of prematurity in preterm infants
    Ufuk Çakır, Cuneyt Tayman
    Journal of Pediatric Endocrinology and Metabolism.2019; 32(1): 65.     CrossRef
  • Understanding hypothyroidism in Unani medicine
    Md. Anzar Alam, Mohd Aleemuddin Quamri, Ghulamuddin Sofi, Barkati Md. Tarique
    Journal of Integrative Medicine.2019; 17(6): 387.     CrossRef
  • Team Approach: Multidisciplinary Treatment of Hip Fractures in Elderly Patients
    Wender Figved, Marius Myrstad, Ingvild Saltvedt, Merete Finjarn, Liv Marie Flaten Odland, Frede Frihagen
    JBJS Reviews.2019; 7(6): e6.     CrossRef
  • Effect of sodium levothyroxine on histomorphometry, histopathology, histochemistry, and immunohistochemistry of articular cartilage in female mice
    Simin Fazelipour, Minoo Shafii, Mahsa Hadipour Jahromi, Zahra Tootian, Mohammad Taghi Sheibani, Hassan Morovvati, Marzieh Minaei, Anahita Shahriari, Pooneh Koochaki, Safora Karimi
    Comparative Clinical Pathology.2018; 27(1): 45.     CrossRef
  • High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone–Suppressive Therapy for Thyroid Carcinoma
    Gherardo Mazziotti, Anna Maria Formenti, Stefano Frara, Roberto Olivetti, Giuseppe Banfi, Maurizio Memo, Roberto Maroldi, Raffaele Giubbini, Andrea Giustina
    The Journal of Clinical Endocrinology & Metabolism.2018; 103(3): 956.     CrossRef
  • Subclinical thyrotoxicosis and bone
    M. Doga, A.M. Formenti, S. Frara, M. Memo, A. Giustina, G. Mazziotti
    Current Opinion in Endocrine and Metabolic Researc.2018;[Epub]     CrossRef
  • Effects of Abnormal Thyroid Function Status to Bone Metabolism
    Hwa Young Ahn
    International Journal of Thyroidology.2018; 11(1): 21.     CrossRef
  • RETRACTED ARTICLE: The relationship between subclinical thyroid dysfunction and the risk of fracture or low bone mineral density: a systematic review and meta-analysis of cohort studies
    Ruifei Yang, Liang Yao, Yuan Fang, Jing Sun, Tiankang Guo, Kehu Yang, Limin Tian
    Journal of Bone and Mineral Metabolism.2018; 36(2): 209.     CrossRef
  • MANAGEMENT OF ENDOCRINE DISEASE: l-Thyroxine replacement therapy in the frail elderly: a challenge in clinical practice
    R M Ruggeri, F Trimarchi, B Biondi
    European Journal of Endocrinology.2017; 177(4): R199.     CrossRef
  • THE IMPACT OF AGE IN THE MANAGEMENT OF HYPOTHYROIDISM: RESULTS OF A NATIONWIDE SURVEY
    Maria Papaleontiou, Brittany L. Gay, Nazanene H. Esfandiari, Sarah T. Hawley, Megan R. Haymart
    Endocrine Practice.2016; 22(6): 708.     CrossRef
  • TSH Suppression after Differentiated Thyroid Cancer Surgery and Osteoporosis
    Kyoung Sik Park
    Korean Journal of Endocrine Surgery.2016; 16(1): 1.     CrossRef
  • TSH Suppression after Differentiated Thyroid Cancer Surgery and Osteoporosis
    Kyoung Sik Park
    Korean Journal of Endocrine Surgery.2016; 16(1): 1.     CrossRef
  • Role of Thyroid Hormones in Skeletal Development and Bone Maintenance
    J. H. Duncan Bassett, Graham R. Williams
    Endocrine Reviews.2016; 37(2): 135.     CrossRef

JPMPH : Journal of Preventive Medicine and Public Health